Experimental Drug Reverses PTSD Symptoms in Mice – Already in Human Trials


Excessive levels of GABA released by astrocytes impair the brain’s ability to extinguish fear responses in PTSD, but a newly identified drug target offers promising hope for treatment. Many people with post-traumatic stress disorder (PTSD) continue to relive painful memories long after the actual threat is gone. Their brains seem unable to let go of […]

Source link

Related Articles

Related posts:

  1. FDA Panel Rejects Combo Drug for PTSD
  2. FDA Advisory Committee Votes Against Recommending Brexpiprazole Plus Sertraline for PTSD
  3. Anti-Alcohol Drug Sales on the Rise in Russia
  4. Canada’s new drug pricing guidelines are industry-friendly
See also  FDA seeks to classify 7-OH as Schedule 1 drug amid addiction concerns
↑
Exit mobile version